PRO Medicus Limited
PMCUF
$200.91
$3.911.99%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 28.80% | 26.39% | 31.13% | 34.19% | 26.76% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 28.80% | 26.39% | 31.13% | 34.19% | 26.76% |
| Cost of Revenue | 18.22% | 16.16% | -11.67% | -9.64% | -50.52% |
| Gross Profit | 28.82% | 26.40% | 31.23% | 34.29% | 27.05% |
| SG&A Expenses | 22.63% | 20.33% | 17.15% | 19.89% | 14.97% |
| Depreciation & Amortization | -3.31% | -5.13% | -28.43% | -26.75% | 0.31% |
| Other Operating Expenses | -177.22% | -175.76% | -2.84% | -0.55% | -44.32% |
| Total Operating Expenses | 15.35% | 13.19% | 8.28% | 10.81% | 9.77% |
| Operating Income | 33.76% | 31.25% | 42.89% | 46.23% | 34.42% |
| Income Before Tax | 31.95% | 29.48% | 46.05% | 49.47% | 36.26% |
| Income Tax Expenses | 30.49% | 28.05% | 54.72% | 58.33% | 34.04% |
| Earnings from Continuing Operations | 32.57% | 30.08% | 42.73% | 46.06% | 37.23% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 32.57% | 30.08% | 42.73% | 46.06% | 37.23% |
| EBIT | 33.76% | 31.25% | 42.89% | 46.23% | 34.42% |
| EBITDA | 33.78% | 31.28% | 42.75% | 46.09% | 34.29% |
| EPS Basic | 32.56% | 30.03% | 42.71% | 46.04% | 37.20% |
| Normalized Basic EPS | 31.11% | 28.75% | 47.21% | 50.57% | 37.01% |
| EPS Diluted | 32.54% | 30.08% | 42.82% | 46.16% | 37.01% |
| Normalized Diluted EPS | 30.98% | 28.61% | 47.36% | 50.82% | 36.90% |
| Average Basic Shares Outstanding | 0.03% | 0.03% | 0.03% | 0.03% | 0.00% |
| Average Diluted Shares Outstanding | 0.09% | 0.09% | -0.07% | -0.07% | 0.12% |
| Dividend Per Share | 32.55% | 30.15% | 38.84% | 42.28% | 27.64% |
| Payout Ratio | 0.02% | 0.02% | -0.09% | -0.09% | 0.00% |